Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
Accenture
McKinsey
Medtronic
UBS

Generated: March 26, 2019

DrugPatentWatch Database Preview

NEUPOGEN Drug Profile

« Back to Dashboard

US Patents for NEUPOGEN

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Try a Free Trial Bayer Intellectual Property GMBH (Monheim, DE) ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Try a Free Trial EnBio Limited (Dublin, IE) ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Try a Free Trial CARDIONOVUM Sp.z.o.o. (Warsaw, PL) ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Try a Free Trial Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Try a Free Trial GENMAB A/S (Copenhagen V, DK) ➤ Try a Free Trial RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for NEUPOGEN

Supplementary Protection Certificates for NEUPOGEN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
546 Finland ➤ Try a Free Trial
PA2010007,C1534390 Lithuania ➤ Try a Free Trial PRODUCT NAME: ELTROMBOPAGUM OLAMINUM; REGISTRATION NO/DATE: EU/1/10/612/001, 2010-03-11 EU/1/10/612/002, 2010-03-11 EU/1/10/612/003, 2010-03-11 EU/1/10/612/004, 2010-03-11 EU/1/10/612/005, 2010-03-11 EU/1/10/612/006 20100311
C300687 Netherlands ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
2014/048 Ireland ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
91 3-2010 Slovakia ➤ Try a Free Trial PRODUCT NAME: ELTROMBOPAG; FIRST REGISTRATION NO/DATE: EU/1/10/612/001, EU/1/10/612/002, EU/1/10/612/003, EU/1/10/612/004, EU/1/10/612/005, EU/1/10/612/006; 20100311
CR 2014 00047 Denmark ➤ Try a Free Trial PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928/001-002 20140527
C20140027 00115 Estonia ➤ Try a Free Trial PRODUCT NAME: SILTUKSIMAB;REG NO/DATE: K(2014)3557 (LOPLIK) 27.05.2014
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Merck
US Army
Fuji
Colorcon
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.